Drug Shortage Report for CISPLATIN INJECTION

Last updated on 2021-04-29 History
Report ID 133457
Drug Identification Number 02403188
Brand name CISPLATIN INJECTION
Common or Proper name CISPLATIN INJECTION 1MG/ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CISPLATIN
Strength(s) 1.0MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50ml
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-03
Estimated end date 2021-04-30
Actual end date 2021-04-28
Shortage status Resolved
Updated date 2021-04-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-04-29 French Compare
v3 2021-04-29 English Compare
v2 2021-02-05 French Compare
v1 2021-02-05 English Compare

Showing 1 to 4 of 4